Abbott Laboratories vs. Johnson & Johnson
Abbott Laboratories (ABT) comes out ahead, leading on 2 of 3 compared factors.
Size & Scale
| ABT | JNJ | |
|---|---|---|
| Market Cap | $190.62 billion | $651.32 billion |
JNJ leads on 1 of 1 size & scale factors.
Dividend
| ABT | JNJ | |
|---|---|---|
| Dividend Yield | 2.29% | 2.01% |
ABT leads on 1 of 1 dividend factors.
Risk & Sentiment
| ABT | JNJ | |
|---|---|---|
| Short Interest | 0.57% | 0.67% |
ABT leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, JNJ overview, JNJ financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.